Northwest Biotherapeutics Inc (NASDAQOTH:NWBO)

CAPS Rating: 1 out of 5

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

35 Outperform
35 Underperform
 

All-Star Players

3 Outperform
28 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NWBO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

martynanasi (94.29)
Submitted March 11, 2014

Recently approved drug DCVax-L apporved in Germany ahead of phase III trail completion. WIll be allowed to prescribed for 5yr and can be extended. Previous trials point to sustain life span of existing brain cancer tumor patients. See huge upside

zzlangerhans (99.62)
Submitted October 22, 2016

Every once in a while I check in to see what Northwest is up to. Recently there was a price spike but I didn't have time to look into it. It turns out there was nothing to justify it. Northwest Bio doesn't have the guts to issue an earnings PR,… More

NWBO VS S&P 500 (SPY)

NWBO Summary

Recent Community Commentary

Read the most recent pitches from players about NWBO.

Recs

1
Member Avatar zzlangerhans (99.62) Submitted: 10/21/2016 11:16:46 PM : Underperform Start Price: $0.56 NWBO Score: +99.51

Every once in a while I check in to see what Northwest is up to. Recently there was a price spike but I didn't have time to look into it. It turns out there was nothing to justify it. Northwest Bio doesn't have the guts to issue an earnings PR, likely because they would have to admit they are making no clinical progress but continuing to feed cash from dilutive financings into Linda Powers' slush fund Cognate. They filed a 10Q as required but it contains nothing material regarding their progress or lack thereof in clinical trials. The one positive is that it does appear that the stock is in a death spiral with successive financings at lower and lower share price that are unable to keep up with the quarterly burn. The next 10Q should be interesting. Of course, given Northwest's history, there's no limit to the reverse splitting, nonsense PR spouting we might expect once Powers is backed into a corner.

Recs

0
Member Avatar NHWeston102 (70.53) Submitted: 5/23/2016 2:43:02 PM : Underperform Start Price: $0.77 NWBO Score: +114.73

Collapsing.

Recs

0
Member Avatar goodguygonebad (< 20) Submitted: 2/24/2015 7:05:46 PM : Outperform Start Price: $6.80 NWBO Score: -134.41

NWBO will present data from DCVAX-direct phase I trial as well as DCVAX-L phase I and II trials. Presentation will demonstrate SIGNIFICANT efficacy for both drugs, pushing stock higher. I estimate $10 - $12 per share.

Leaderboard

Find the members with the highest scoring picks in NWBO.

Score Leader

whatsthepoint

whatsthepoint (99.98) Score: +306.60

The Score Leader is the player with the highest score across all their picks in NWBO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
walt373 99.86 8/19/2011 Underperform 5Y $8.00 -97.42% +157.53% +254.96 0 Comment
walt393 99.91 8/18/2011 Underperform 5Y $7.68 -97.32% +149.71% +247.03 0 Comment
Europecv 29.50 10/18/2011 Underperform 5Y $9.28 -97.78% +142.14% +239.92 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. cjlee001 86.89 10/27/2011 Underperform 5Y $8.89 -97.68% +127.93% +225.61 0 Comment
HedgeFund007 95.91 10/28/2011 Underperform 1Y $8.32 -97.52% +127.27% +224.80 0 Comment
wagnerf60 23.14 6/2/2011 Underperform 5Y $14.00 -98.53% +121.76% +220.29 0 Comment
williamstep 98.63 5/23/2011 Underperform 5Y $10.58 -98.05% +120.55% +218.61 0 Comment
vettelvettel 99.04 5/23/2011 Underperform 5Y $10.72 -98.08% +120.52% +218.60 0 Comment
HikerAnthony 96.65 5/26/2011 Underperform 5Y $11.36 -98.19% +120.34% +218.52 0 Comment
thefooloffoools 98.48 5/23/2011 Underperform 5Y $9.15 -97.75% +120.42% +218.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.75 5/28/2014 Underperform 3W $6.14 -96.64% +52.01% +148.65 0 Comment
tracksummerstree 90.86 3/12/2014 Outperform NS $8.53 -97.58% +56.13% -153.72 0 Comment
TrackOppenheimer 71.62 10/16/2013 Outperform NS $3.52 +126.99% +9.47% +117.52 3/12/2014 @ $7.99 0 Comment

Featured Broker Partners


Advertisement